Literature DB >> 19272531

Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice.

Xin Chen1, Robin Schneider-Broussard, Debra Hollowell, Mark McArthur, Collene R Jeter, Fernando Benavides, John DiGiovanni, Dean G Tang.   

Abstract

The cell-of-origin has a great impact on the types of tumors that develop and the stem/progenitor cells have long been considered main targets of malignant transformation. The SV40 (SV40-Simian Virus 40) large T and small t antigens (T/t), have been targeted to multiple-differentiated cellular compartments in transgenic mice. In most of these studies, transgenic animals develop tumors without apparent defects in animal development. In this study, we used the bovine keratin 5 (BK5) promoter to target the T/t antigens to stem/progenitor cell-containing cytokeratin 5 (CK5) cellular compartment. A transgene construct, BK5-T/t, was made and microinjected into the male pronucleus of FVB/N mouse oocytes. After implanting approximately 1700 embryos, only 7 transgenics were obtained, including 4 embryos (E9.5, E13, E15, and E20) and 3 postnatal animals, which died at P1, P2, and P18, respectively. Immunohistological analysis revealed aberrant differentiation and prominent hyperplasia in several transgenic CK5 tissues, especially the upper digestive organs (tongue, oral mucosa, esophagus, and forestomach) and epidermis, the latter of which also showed focal dysplasia. Altogether, these results indicate that constitutive expression of the T/t antigens in CK5 cellular compartment results in abnormal epithelial differentiation and leads to embryonic/perinatal animal lethality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19272531      PMCID: PMC2680132          DOI: 10.1016/j.diff.2008.10.011

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  41 in total

1.  Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.

Authors:  S M Magdaleno; G Wang; V L Mireles; M K Ray; M J Finegold; F J DeMayo
Journal:  Cell Growth Differ       Date:  1997-02

2.  E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.

Authors:  A M Pierce; R Schneider-Broussard; I B Gimenez-Conti; J L Russell; C J Conti; D G Johnson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted.

Authors:  K Brown; D Strathdee; S Bryson; W Lambie; A Balmain
Journal:  Curr Biol       Date:  1998-04-23       Impact factor: 10.834

4.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.

Authors:  Russell D Klein; Carolyn S Van Pelt; Anita L Sabichi; Jorge Dela Cerda; Susan M Fischer; Gerhard Fürstenberger; Karin Müller-Decker
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

6.  Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

Authors:  I G Maroulakou; M Anver; L Garrett; J E Green
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

7.  Prostate cancer in a transgenic mouse.

Authors:  N M Greenberg; F DeMayo; M J Finegold; D Medina; W D Tilley; J O Aspinall; G R Cunha; A A Donjacour; R J Matusik; J M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development.

Authors:  A Ramírez; A Bravo; J L Jorcano; M Vidal
Journal:  Differentiation       Date:  1994-11       Impact factor: 3.880

9.  Programming gene expression in developing epidermis.

Authors:  C Byrne; M Tainsky; E Fuchs
Journal:  Development       Date:  1994-09       Impact factor: 6.868

10.  The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14.

Authors:  C Lloyd; Q C Yu; J Cheng; K Turksen; L Degenstein; E Hutton; E Fuchs
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  4 in total

Review 1.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

2.  Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Authors:  M V Suraneni; R Schneider-Broussard; J R Moore; T C Davis; C J Maldonado; H Li; R A Newman; D Kusewitt; J Hu; P Yang; D G Tang
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

3.  In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.

Authors:  Mark A Badeaux; Collene R Jeter; Shuai Gong; Bigang Liu; Mahipal V Suraneni; Joyce Rundhaug; Susan M Fischer; Tao Yang; Donna Kusewitt; Dean G Tang
Journal:  Cell Cycle       Date:  2013-06-26       Impact factor: 4.534

4.  Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.

Authors:  Bigang Liu; Shuai Gong; Qiuhui Li; Xin Chen; John Moore; Mahipal V Suraneni; Mark D Badeaux; Collene R Jeter; Jianjun Shen; Rashid Mehmood; Qingxia Fan; Dean G Tang
Journal:  Oncotarget       Date:  2017-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.